AXSM
Axsome Therapeutics, Inc.
Stock
$179.25−2.82 (−1.55%)Close Oct 2, 2026
- Revenue, 2025
- $638M
- YoY, 2025
- +65.5%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $638M | +65.5% |
| 2024 | $386M | +42.5% |
| 2023 | $271M | +440.8% |
| 2022 | $50M | — |
Axsome Therapeutics, Inc.
$179.25−2.82 (−1.55%)Close Oct 2, 2026
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $638M | +65.5% |
| 2024 | $386M | +42.5% |
| 2023 | $271M | +440.8% |
| 2022 | $50M | — |